Effects of obesity and estradiol on Na+/K+-ATPase and their relevance to cardiovascular diseases

Manfredi Rizzo, Dragana Nikolic, Manfredi Rizzo, Alan J. Stewart, Predrag Bjelogrlic, Aleksandra Jovanovic, Esma R. Isenovic, Niki Katsiki, Milan Obradovic, Mohamed Haidara

Risultato della ricerca: Article

14 Citazioni (Scopus)

Abstract

Obesity is associated with aberrant sodium/potassium-ATPase (Na+/K+-ATPase) activity, apparently linked to hyperglycemic hyperinsulinemia, which may repress or inactivate the enzyme. The reduction of Na+/K+-ATPase activity in cardiac tissue induces myocyte death and cardiac dysfunction, leading to the development of myocardial dilation in animal models; this has also been documented in patients with heart failure (HF). During several pathological situations (cardiac insufficiency and HF) and in experimental models (obesity), the heart becomes more sensitive to the effect of cardiac glycosides, due to a decrease in Na+/K+-ATPase levels. The primary female sex steroid estradiol has long been recognized to be important in a wide variety of physiological processes. Numerous studies, including ours, have shown that estradiol is one of the major factors controlling the activity and expression of Na+/K+-ATPase in the cardiovascular (CV) system. However, the effects of estradiol on Na+/K+-ATPase in both normal and pathological conditions, such as obesity, remain unclear. Increasing our understanding of the molecular mechanisms by which estradiol mediates its effects on Na+/K+-ATPase function may help to develop new strategies for the treatment of CV diseases. Herein, we discuss the latest data from animal and clinical studies that have examined how pathophysiological conditions such as obesity and the action of estradiol regulate Na+/K+-ATPase activity.
Lingua originaleEnglish
pagine (da-a)R13-R23
Numero di pagine11
RivistaJournal of Endocrinology
Volume218
Stato di pubblicazionePublished - 2013

Fingerprint

Estradiol
Cardiovascular Diseases
Obesity
Heart Failure
Physiological Phenomena
Sodium-Potassium-Exchanging ATPase
Cardiac Glycosides
Hyperinsulinism
Cardiovascular System
sodium-translocating ATPase
Cardiac Myocytes
Dilatation
Theoretical Models
Animal Models
Steroids
Enzymes

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cita questo

Rizzo, M., Nikolic, D., Rizzo, M., Stewart, A. J., Bjelogrlic, P., Jovanovic, A., ... Haidara, M. (2013). Effects of obesity and estradiol on Na+/K+-ATPase and their relevance to cardiovascular diseases. Journal of Endocrinology, 218, R13-R23.

Effects of obesity and estradiol on Na+/K+-ATPase and their relevance to cardiovascular diseases. / Rizzo, Manfredi; Nikolic, Dragana; Rizzo, Manfredi; Stewart, Alan J.; Bjelogrlic, Predrag; Jovanovic, Aleksandra; Isenovic, Esma R.; Katsiki, Niki; Obradovic, Milan; Haidara, Mohamed.

In: Journal of Endocrinology, Vol. 218, 2013, pag. R13-R23.

Risultato della ricerca: Article

Rizzo, M, Nikolic, D, Rizzo, M, Stewart, AJ, Bjelogrlic, P, Jovanovic, A, Isenovic, ER, Katsiki, N, Obradovic, M & Haidara, M 2013, 'Effects of obesity and estradiol on Na+/K+-ATPase and their relevance to cardiovascular diseases', Journal of Endocrinology, vol. 218, pagg. R13-R23.
Rizzo, Manfredi ; Nikolic, Dragana ; Rizzo, Manfredi ; Stewart, Alan J. ; Bjelogrlic, Predrag ; Jovanovic, Aleksandra ; Isenovic, Esma R. ; Katsiki, Niki ; Obradovic, Milan ; Haidara, Mohamed. / Effects of obesity and estradiol on Na+/K+-ATPase and their relevance to cardiovascular diseases. In: Journal of Endocrinology. 2013 ; Vol. 218. pagg. R13-R23.
@article{7eac72f267914a9fa8a53dd5fb75ebdd,
title = "Effects of obesity and estradiol on Na+/K+-ATPase and their relevance to cardiovascular diseases",
abstract = "Obesity is associated with aberrant sodium/potassium-ATPase (Na+/K+-ATPase) activity, apparently linked to hyperglycemic hyperinsulinemia, which may repress or inactivate the enzyme. The reduction of Na+/K+-ATPase activity in cardiac tissue induces myocyte death and cardiac dysfunction, leading to the development of myocardial dilation in animal models; this has also been documented in patients with heart failure (HF). During several pathological situations (cardiac insufficiency and HF) and in experimental models (obesity), the heart becomes more sensitive to the effect of cardiac glycosides, due to a decrease in Na+/K+-ATPase levels. The primary female sex steroid estradiol has long been recognized to be important in a wide variety of physiological processes. Numerous studies, including ours, have shown that estradiol is one of the major factors controlling the activity and expression of Na+/K+-ATPase in the cardiovascular (CV) system. However, the effects of estradiol on Na+/K+-ATPase in both normal and pathological conditions, such as obesity, remain unclear. Increasing our understanding of the molecular mechanisms by which estradiol mediates its effects on Na+/K+-ATPase function may help to develop new strategies for the treatment of CV diseases. Herein, we discuss the latest data from animal and clinical studies that have examined how pathophysiological conditions such as obesity and the action of estradiol regulate Na+/K+-ATPase activity.",
author = "Manfredi Rizzo and Dragana Nikolic and Manfredi Rizzo and Stewart, {Alan J.} and Predrag Bjelogrlic and Aleksandra Jovanovic and Isenovic, {Esma R.} and Niki Katsiki and Milan Obradovic and Mohamed Haidara",
year = "2013",
language = "English",
volume = "218",
pages = "R13--R23",
journal = "Journal of Endocrinology",
issn = "0022-0795",
publisher = "Society for Endocrinology",

}

TY - JOUR

T1 - Effects of obesity and estradiol on Na+/K+-ATPase and their relevance to cardiovascular diseases

AU - Rizzo, Manfredi

AU - Nikolic, Dragana

AU - Rizzo, Manfredi

AU - Stewart, Alan J.

AU - Bjelogrlic, Predrag

AU - Jovanovic, Aleksandra

AU - Isenovic, Esma R.

AU - Katsiki, Niki

AU - Obradovic, Milan

AU - Haidara, Mohamed

PY - 2013

Y1 - 2013

N2 - Obesity is associated with aberrant sodium/potassium-ATPase (Na+/K+-ATPase) activity, apparently linked to hyperglycemic hyperinsulinemia, which may repress or inactivate the enzyme. The reduction of Na+/K+-ATPase activity in cardiac tissue induces myocyte death and cardiac dysfunction, leading to the development of myocardial dilation in animal models; this has also been documented in patients with heart failure (HF). During several pathological situations (cardiac insufficiency and HF) and in experimental models (obesity), the heart becomes more sensitive to the effect of cardiac glycosides, due to a decrease in Na+/K+-ATPase levels. The primary female sex steroid estradiol has long been recognized to be important in a wide variety of physiological processes. Numerous studies, including ours, have shown that estradiol is one of the major factors controlling the activity and expression of Na+/K+-ATPase in the cardiovascular (CV) system. However, the effects of estradiol on Na+/K+-ATPase in both normal and pathological conditions, such as obesity, remain unclear. Increasing our understanding of the molecular mechanisms by which estradiol mediates its effects on Na+/K+-ATPase function may help to develop new strategies for the treatment of CV diseases. Herein, we discuss the latest data from animal and clinical studies that have examined how pathophysiological conditions such as obesity and the action of estradiol regulate Na+/K+-ATPase activity.

AB - Obesity is associated with aberrant sodium/potassium-ATPase (Na+/K+-ATPase) activity, apparently linked to hyperglycemic hyperinsulinemia, which may repress or inactivate the enzyme. The reduction of Na+/K+-ATPase activity in cardiac tissue induces myocyte death and cardiac dysfunction, leading to the development of myocardial dilation in animal models; this has also been documented in patients with heart failure (HF). During several pathological situations (cardiac insufficiency and HF) and in experimental models (obesity), the heart becomes more sensitive to the effect of cardiac glycosides, due to a decrease in Na+/K+-ATPase levels. The primary female sex steroid estradiol has long been recognized to be important in a wide variety of physiological processes. Numerous studies, including ours, have shown that estradiol is one of the major factors controlling the activity and expression of Na+/K+-ATPase in the cardiovascular (CV) system. However, the effects of estradiol on Na+/K+-ATPase in both normal and pathological conditions, such as obesity, remain unclear. Increasing our understanding of the molecular mechanisms by which estradiol mediates its effects on Na+/K+-ATPase function may help to develop new strategies for the treatment of CV diseases. Herein, we discuss the latest data from animal and clinical studies that have examined how pathophysiological conditions such as obesity and the action of estradiol regulate Na+/K+-ATPase activity.

UR - http://hdl.handle.net/10447/132732

UR - http://www.ncbi.nlm.nih.gov/pubmed/23785175

M3 - Article

VL - 218

SP - R13-R23

JO - Journal of Endocrinology

JF - Journal of Endocrinology

SN - 0022-0795

ER -